Zawadzki, M., Karczewska-Kupczewska, M., & Gasparotto Junior, A. (2026). Direct or Indirect Action? Mechanisms of the Antiatherosclerotic Effects of Glucagon‐Like Peptide‐1 Receptor Agonists. Cardiovascular Therapeutics, 2026, 1. https://doi.org/10.1155/cdr/8388511
Chicago Style (17th ed.) CitationZawadzki, Michał, Monika Karczewska-Kupczewska, and Arquimedes Gasparotto Junior. "Direct or Indirect Action? Mechanisms of the Antiatherosclerotic Effects of Glucagon‐Like Peptide‐1 Receptor Agonists." Cardiovascular Therapeutics 2026 (2026): 1. https://doi.org/10.1155/cdr/8388511.
MLA (9th ed.) CitationZawadzki, Michał, et al. "Direct or Indirect Action? Mechanisms of the Antiatherosclerotic Effects of Glucagon‐Like Peptide‐1 Receptor Agonists." Cardiovascular Therapeutics, vol. 2026, 2026, p. 1, https://doi.org/10.1155/cdr/8388511.